| Literature DB >> 27763551 |
Daryl C Yang1,2, Jennifer R Deuis3, Daniel Dashevsky4, James Dobson5, Timothy N W Jackson6, Andreas Brust7, Bing Xie8, Ivan Koludarov9, Jordan Debono10, Iwan Hendrikx11, Wayne C Hodgson12, Peter Josh13, Amanda Nouwens14, Gregory J Baillie15, Timothy J C Bruxner16, Paul F Alewood17, Kelvin Kok Peng Lim18, Nathaniel Frank19, Irina Vetter20,21, Bryan G Fry22.
Abstract
Millions of years of evolution have fine-tuned the ability of venom peptides to rapidly incapacitate both prey and potential predators. Toxicofera reptiles are characterized by serous-secreting mandibular or maxillary glands with heightened levels of protein expression. These glands are the core anatomical components of the toxicoferan venom system, which exists in myriad points along an evolutionary continuum. Neofunctionalisation of toxins is facilitated by positive selection at functional hotspots on the ancestral protein and venom proteins have undergone dynamic diversification in helodermatid and varanid lizards as well as advanced snakes. A spectacular point on the venom system continuum is the long-glanded blue coral snake (Calliophis bivirgatus), a specialist feeder that preys on fast moving, venomous snakes which have both a high likelihood of prey escape but also represent significant danger to the predator itself. The maxillary venom glands of C. bivirgatus extend one quarter of the snake's body length and nestle within the rib cavity. Despite the snake's notoriety its venom has remained largely unstudied. Here we show that the venom uniquely produces spastic paralysis, in contrast to the flaccid paralysis typically produced by neurotoxic snake venoms. The toxin responsible, which we have called calliotoxin (δ-elapitoxin-Cb1a), is a three-finger toxin (3FTx). Calliotoxin shifts the voltage-dependence of NaV1.4 activation to more hyperpolarised potentials, inhibits inactivation, and produces large ramp currents, consistent with its profound effects on contractile force in an isolated skeletal muscle preparation. Voltage-gated sodium channels (NaV) are a particularly attractive pharmacological target as they are involved in almost all physiological processes including action potential generation and conduction. Accordingly, venom peptides that interfere with NaV function provide a key defensive and predatory advantage to a range of invertebrate venomous species including cone snails, scorpions, spiders, and anemones. Enhanced activation or delayed inactivation of sodium channels by toxins is associated with the extremely rapid onset of tetanic/excitatory paralysis in envenomed prey animals. A strong selection pressure exists for the evolution of such toxins where there is a high chance of prey escape. However, despite their prevalence in other venomous species, toxins causing delay of sodium channel inhibition have never previously been described in vertebrate venoms. Here we show that NaV modulators, convergent with those of invertebrates, have evolved in the venom of the long-glanded coral snake. Calliotoxin represents a functionally novel class of 3FTx and a structurally novel class of NaV toxins that will provide significant insights into the pharmacology and physiology of NaV. The toxin represents a remarkable case of functional convergence between invertebrate and vertebrate venom systems in response to similar selection pressures. These results underscore the dynamic evolution of the Toxicofera reptile system and reinforces the value of using evolution as a roadmap for biodiscovery.Entities:
Keywords: evolution; neurotoxin; pharmacology; sodium channel; toxicofera; venom
Mesh:
Substances:
Year: 2016 PMID: 27763551 PMCID: PMC5086663 DOI: 10.3390/toxins8100303
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Isolation of calliotoxin (δ-elapitoxin-Cb1a), the first NaV activator from snake venom. (a) Specimen of Calliophis bivirgatus, the blue coral snake (photo by Tom Charlton); (b) Dissected preserved 112 cm Calliophis bivirgatus specimen with 29 cm elongated venom glands (arrows); (c) C. bivirgatus crude venom (10 μg/mL) elicits rising contractions of the skeletal muscle in the chick biventer cervicis nerve-muscle preparation while abolishing nerve mediated contractions; (d) Pre-treatment with tetrodotoxin (0.1 μM) prevents the increase in baseline tension elicited by crude C. bivirgatus venom. * p Value = 0.0272, significantly different from venom alone, unpaired t-test; (e) RP-HPLC fractionation of crude C. bivirgatus venom (150 μg) on a BDS Hypersil C18 column. Dotted line; gradient (25.6%–56.2% solvent B). Solid grey line shows elution of purified calliotoxin (green peak) under identical conditions. Arrow indicates active fraction; (f) Left axis (green line): orthogonal purification of RP-HPLC fraction containing calliotoxin on a Synergi-Hydro RP column. Dotted line; gradient (36.5%–42.1% solvent B). Right axis (black line/filled circles): response of SH-SY5Y cells to corresponding 20 s-fractions. Fractions indicated by blue circles were collected for sequencing and pharmacological analysis; (g) The fraction containing purified native calliotoxin is dominated by a single isotopic mass of 6725.9 Da.
Figure 2Sequence of calliotoxin (δ-elapitoxin-Cb1a) and the most closely related three-finger toxins. Homology to known three-finger toxins (3FTxs) was determined using BLAST and multiple sequence alignment conducted with CLUSTAL Omega (1.2.2). Calliotoxin (δ-elapitoxin-Cb1a; blue sequence) is most closely related to ρ-EPTX-Dp1b (P25518.1; Dendroaspis polylepis polylepis; 50% sequence identity), ρ-EPTX-Dp1a (P80495.1; Dendroaspis polylepis polylepis; 50% sequence identity), ρ-EPTX-Da1a (P85092.1; Dendroaspis angusticeps; 49% sequence identity), and ρ-EPTX-Da1b (P86419.1; Dendroaspis angusticeps; 53% sequence identity), three-finger toxins with activity at α1-adrenoreceptors, as well as muscarinic toxin 3 (P81031.2; Dendroaspis angusticeps; 49% sequence identity) targeting the mAChR and Toxin CM-12 (P62394.1; Naja haje haje; 42% sequence identity), Cardiotoxin 7 (P49122.1; Naja atra; 42% sequence identity), and Three-finger toxin 6 (JAS05190.1; Micrurus tener; 47% sequence identity) with unknown pharmacological activity. Conserved ancestral cysteines shown in bold, disulphide-bond pattern shown in black lines.
Figure 3Activity of calliotoxin (200 nM) in HEK-293 cells heterologously expressing hNaV1.4 assessed by automated patch clamping. (a) Representative trace of sodium currents before (upper) and after addition of calliotoxin (lower) elicited by depolarizing steps between −80 and +60 mV in 10 mV increments. The red trace highlights the depolarizing step to −20 mV; (b) Current-voltage relationship before and after the addition of calliotoxin; (c) Voltage-dependence of activation (circles) and voltage-dependence of steady-state fast inactivation (squares) before and after addition of calliotoxin; (d) Voltage-dependence of fast inactivation time constants before and after addition of calliotoxin; (e) Average persistent current elicited 40–50 ms after a −20 mV depolarizing step before and after addition of calliotoxin; (f) Representative trace of ramp sodium current before and after addition of calliotoxin; (g) Peak inward current elicited by a depolarizing ramp (2.4 mV/ms) before and after addition of calliotoxin. Data are shown as mean ± SEM with n = 3 replicates; (h) Calliotoxin-induced effects are mediated through NaV channels. Calliotoxin-induced Ca2+ responses in SH-SY5Y cells were inhibited by tetrodotoxin (TTX) (1 μM) but not the nAChR antagonist d-tubocurarine (10 μM), the M1 mAChR antagonist pirenzepine (100 μM), or the α1-adrenoreceptor antagonist prazosin (10 μM).